Larimar Therapeutics | Investor Presentation Deck | 44 slides · page 30 of 44
The slide highlights the safety profile of the drug candidate, specifically noting the absence of serious adverse events and the nature of injection site reactions.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
list 4/4 paragraph 1/1 title 2/2
Components 7
bullet bullet bullet bullet paragraph action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.